This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gurumurthy, S.
Right arrow Articles by Rangnekar, V. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gurumurthy, S.
Right arrow Articles by Rangnekar, V. M.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, February 2005, p. 1146-1161, Vol. 25, No. 3
0270-7306/05/$08.00+0     doi:10.1128/MCB.25.3.1146-1161.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Phosphorylation of Par-4 by Protein Kinase A Is Critical for Apoptosis

Sushma Gurumurthy,1 Anindya Goswami,2 Krishna Murthi Vasudevan,3 and Vivek M. Rangnekar1,2,3,4*

Graduate Center for Toxicology, Departments of,1 Radiation Medicine,2 Microbiology, Immunology, and Molecular Genetics,3 Markey Cancer Center, University of Kentucky, Lexington, Kentucky4

Received 16 September 2004/ Returned for modification 20 October 2004/ Accepted 28 October 2004

Despite distinct dissimilarities, diverse cancers express several common protumorigenic traits. We present here evidence that the proapoptotic protein Par-4 utilizes one such common tumorigenic trait to become selectively activated and induce apoptosis in cancer cells. Elevated protein kinase A (PKA) activity noted in cancer cells activated the apoptotic function of ectopic Par-4 or its SAC (selective for apoptosis induction in cancer cells) domain, which induces apoptosis selectively in cancer cells and not in normal or immortalized cells. PKA preferentially phosphorylated Par-4 at the T155 residue within the SAC domain in cancer cells. Moreover, pharmacological-, peptide-, or small interfering RNA-mediated inhibition of PKA activity in cancer cells resulted in abrogation of both T155 phosphorylation and apoptosis by Par-4. The mechanism of activation of endogenous Par-4 was similar to that of ectopic Par-4, and in response to exogenous stimuli, endogenous Par-4 induced apoptosis by a PKA- and phosphorylated T155-dependent mechanism. Enforced elevation of PKA activity in normal cells resulted in apoptosis by the SAC domain of Par-4 in a T155-dependent manner. Together, these observations suggest that selective apoptosis of cancer cells by the SAC domain of Par-4 involves phosphorylation of T155 by PKA. These findings uncover a novel mechanism engaging PKA, a procancerous activity commonly elevated in most tumor cells, to activate the cancer selective apoptotic action of Par-4.

* Corresponding author. Mailing address: Department of Radiation Medicine, University of Kentucky, Combs Research Building, Rm. 303, 800 Rose St., Lexington, KY 40536. Phone: (859) 257-2677. Fax: (859) 257-9608. E-mail: vmrang01{at}pop.uky.edu.

Molecular and Cellular Biology, February 2005, p. 1146-1161, Vol. 25, No. 3
0022-538X/05/$08.00+0     doi:10.1128/MCB.25.3.1146-1161.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Ye, L., Kynaston, H., Jiang, W. G. (2008). Bone Morphogenetic Protein-9 Induces Apoptosis in Prostate Cancer Cells, the Role of Prostate Apoptosis Response-4. Mol Cancer Res 6: 1594-1606 [Abstract] [Full Text]  
  • Azmi, A. S., Wang, Z., Burikhanov, R., Rangnekar, V. M., Wang, G., Chen, J., Wang, S., Sarkar, F. H., Mohammad, R. M. (2008). Critical role of prostate apoptosis response-4 in determining the sensitivity of pancreatic cancer cells to small-molecule inhibitor-induced apoptosis. Molecular Cancer Therapeutics 7: 2884-2893 [Abstract] [Full Text]  
  • Goswami, A., Qiu, S., Dexheimer, T. S., Ranganathan, P., Burikhanov, R., Pommier, Y., Rangnekar, V. M. (2008). Par-4 Binds to Topoisomerase 1 and Attenuates Its DNA Relaxation Activity. Cancer Res. 68: 6190-6198 [Abstract] [Full Text]  
  • Zhao, Y., Burikhanov, R., Qiu, S., Lele, S. M., Jennings, C. D., Bondada, S., Spear, B., Rangnekar, V. M. (2007). Cancer Resistance in Transgenic Mice Expressing the SAC Module of Par-4. Cancer Res. 67: 9276-9285 [Abstract] [Full Text]  
  • Srinivasan, S., Ranga, R. S., Burikhanov, R., Han, S.-S., Chendil, D. (2007). Par-4-Dependent Apoptosis by the Dietary Compound Withaferin A in Prostate Cancer Cells. Cancer Res. 67: 246-253 [Abstract] [Full Text]  
  • Affar, E. B., Po-shan Luke, M., Gay, F., Calvo, D., Sui, G., Weiss, R. S., Li, E., Shi, Y. (2006). Targeted ablation of par-4 reveals a cell type-specific susceptibility to apoptosis-inducing agents.. Cancer Res. 66: 3456-3462 [Abstract] [Full Text]  
  • Goswami, A., Ranganathan, P., Rangnekar, V. M. (2006). The phosphoinositide 3-kinase/akt1/par-4 axis: a cancer-selective therapeutic target.. Cancer Res. 66: 2889-2892 [Abstract] [Full Text]  
  • O'Donnell, S. M., Holm, G. H., Pierce, J. M., Tian, B., Watson, M. J., Chari, R. S., Ballard, D. W., Brasier, A. R., Dermody, T. S. (2006). Identification of an NF-{kappa}B-Dependent Gene Network in Cells Infected by Mammalian Reovirus. J. Virol. 80: 1077-1086 [Abstract] [Full Text]  
  • El-Deiry, W. S. (2005). Meeting Report: The International Conference on Tumor Progression and Therapeutic Resistance. Cancer Res. 65: 4475-4484 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»